Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Lisa Siegartel, MPH

Merck & Co., Inc.

Disclosure(s): Merck & Co., Inc.: Employee, Ownership Interest

Poster(s):

379 - A budget impact analysis of bezlotoxumab for the management of recurrent Clostridioides difficile infection in the United States
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET